Does the placement of a collagen-fibrin sealant reduce complications of radical inguinal lymph node dissection? - Comparative study in patients with penile cancer
https://doi.org/10.4081/aiua.2022.4.434
Accepted: August 21, 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Objective: Management of patients with penile cancer (PeC) with palpable inguinal lymph nodes (ILNs) relies on radical ILN dissection (RILND). Low burden of nodal metastatic disease may lead to long-lasting survival with surgical management. Nevertheless, RILND involves significant postoperative morbidity. We compared the complications of patients undergoing RILND with (RILND-T) and without (RILND-0T) placement of a collagen-fibrin sealant patch on the resection bed.
Materials and methods: We conducted an observational retrospective study. Data from men submitted to RILND-T and RILND-0T from Jan/2001 to Feb/2022, in a tertiary care centre were compared. The primary endpoint was the overall incidence of complications until 1 month after the procedure and their respective severity in both cohorts (Clavien-Dindo classification system). Secondarily, length of hospital stay (LOHS) was analysed. The placement of a collagen-fibrin sealant patch was left at the surgeon’s discretion.
Results: Seven patients underwent RILND-T and 20 underwent RILND-0T, respectively. There were no differences in pathologic TNM stage nor in the total number of ILNs removed (17 ± 4 vs. 20 ± 8, p = 0.37). Overall, 23 (85.2%) patients had complications. The complication rate was similar in both cohorts (85.7% vs 85%, p = 0.73). Surgical wound infection (3/7 vs. 11/20) and lymphocele (4/7 vs. 11/20) were the most reported complications. Patients undergoing RILND-T were discharged faster (mean length of hospital stay 9 ± 3 vs 19 ± 20 days, p = 0.22).
Conclusions: The application of a collagen-fibrin sealant patch on the resection bed does not seem to reduce the postoperative complication rate in patients undergoing RILND. Nevertheless, a trend towards a shorter LOHS in patients with RILND-T cannot be excluded and should be validated by further studies with a higher number of patients.
H. Sung et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA. Cancer J. Clin., vol. 71, no. 3, pp. 209–249, May 2021.
O. W. Hakenberg, E. S. Minhas, A. Necchi, C. Protzel, N.Watkin, and E. Compérat, “EAU Guidelines on Penile Cancer 2020,” Eur. Assoc. Urol. Guidel. 2020 Ed., pp. 1–38, 2020.
J. S. Barnholtz-Sloan, J. L. Maldonado, J. Pow-sang, and A. R. Guiliano, “Incidence trends in primary malignant penile cancer,” Urol. Oncol., vol. 25, no. 5, pp. 361–367, 2007.
World Health Organization, “Portugal - Global Cancer Observatory,” Globocan 2020, vol. 501, pp. 1–2, 2020.
A. Leone, G. J. Diorio, C. Pettaway, V. Master, and P. E. Spiess, “Contemporary management of patients with penile cancer and lymph node metastasis,” Nat. Rev. Urol., vol. 14, no. 6, pp. 335–347, 2017.
M. R. Pow-Sang, U. Ferreira, J. M. Pow-Sang, A. C. Nardi, and V. Destefano, “Epidemiology and natural history of penile cancer,” Urology, vol. 76, no. 2 Suppl 1, p. S2, 2010.
J. A. P. Leijte, J. M. Kerst, E. Bais, N. Antonini, and S. Horenblas, “Neoadjuvant chemotherapy in advanced penile carcinoma,” Eur. Urol., vol. 52, no. 2, pp. 488–494, Aug. 2007.
J. M. Gopman et al., “Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort,” BJU Int., vol. 116, no. 2, pp. 196–201, 2015.
M. M. Stuiver, R. S. Djajadiningrat, N. M. Graafland, A. D. Vincent, C. Lucas, and S. Horenblas, “Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis,” Eur. Urol., vol. 64, no. 3, pp. 486–492, Sep. 2013.
L. Koifman, D. Hampl, N. Koifman, A. J. Vides, and A. A. Ornellas, “Radical open inguinal lymphadenectomy for penile carcinoma: Surgical technique, early complications and late outcomes,” J. Urol., vol. 190, no. 6, pp. 2086–2092, 2013.
S. Siemer et al., “Efficacy and Safety of TachoSil® as Haemostatic Treatment versus Standard Suturing in Kidney Tumour Resection: A Randomised Prospective Study,” Eur. Urol., vol. 52, no. 4, pp. 1156–1163, 2007.
U. Anegg, J. Lindenmann, V. Matzi, J. Smolle, A. Maier, and F. Smolle-Jüttner, “Efficiency of fleece-bound sealing (TachoSil®) of air leaks in lung surgery: a prospective randomised trial,” Eur. J. Cardio-thoracic Surg., vol. 31, no. 2, pp. 198–202, 2007.
M. Czerny et al., “Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma,” Ann. Thorac. Surg., vol. 77, no. 3, pp. 1028–1032, 2004.
M. Moore et al., “Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial,” J. Am. Coll. Surg., vol. 192, no. 5, pp. 591–599, 2001.
S. Baggio et al., “Efficacy of a collagen-fibrin sealant patch (TachoSil®) as adjuvant treatment in the inguinofemoral lymphadenectomy for vulvar cancer: A double-blind randomized-controlled trial,” Arch. Gynecol. Obstet., vol. 299, no. 5, pp. 1467–1474, 2019.
A. Fawzy, M. A. Balbaa, and A. Gaber, “Role for fibrin glue (sealant) in seroma reduction after inguinal lymphadenectomy; a randomized controlled trial,” Int. J. Surg., vol. 89, p. 105950, May 2021.
R. Tauber et al., “Inguinal lymph node dissection: epidermal vacuum therapy for prevention of wound complications,” J. Plast. Reconstr. Aesthet. Surg., vol. 66, no. 3, pp. 390–396, Mar. 2013.
A. L. H. Gerken et al., “Tissue sealants for the prevention of lymphoceles after radical inguinal lymph node dissection in patients with melanoma: A systematic review and individual patient data meta-analysis,” J. Surg. Oncol., vol. 119, no. 6, pp. 728–736, May 2019.
F. A. M. Saner, A. Schötzau, G. Mackay, V. Heinzelmann-Schwarz, and C. M. Sartorius, “
Fibrin-thrombin sealant does not reduce lymphocele formation in patients with inguinofemoral lymphadenectomy for vulvar cancer
,” Cancer Manag. Res., vol. 11, pp. 3575–3582, Apr. 2019.D. Dindo, N. Demartines, and P. A. Clavien, “Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey,” Ann. Surg., vol. 240, no. 2, pp. 205–213, Aug. 2004.
P. E. Spiess, M. S. Hernandez, and C. A. Pettaway, “Contemporary inguinal lymph node dissection: minimizing complications,” World J. Urol., vol. 27, no. 2, pp. 205–212, 2009.
R. Thuret et al., “A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma,” Ann. Surg. Oncol., vol. 18, no. 2, pp. 439–446, Feb. 2011.
C. Protzel, A. Alcaraz, S. Horenblas, G. Pizzocaro, A. Zlotta, and O. W. Hakenberg, “Lymphadenectomy in the surgical management of penile cancer,” Eur. Urol., vol. 55, no. 5, pp. 1075–1088, May 2009.
S. Abbas and M. Seitz, “Systematic review and meta-analysis of the used surgical techniques to reduce leg lymphedema following radical inguinal nodes dissection,” Surg. Oncol., vol. 20, no. 2, pp. 88–96, 2011.
C. Weldrick et al., “A comparison of fibrin sealant versus standard closure in the reduction of postoperative morbidity after groin dissection: A systematic review and meta-analysis,” Eur. J. Surg. Oncol., vol. 40, no. 11, pp. 1391–1398, 2014.
Y. Cui et al., “Saphenous vein sparing during laparoscopic bilateral inguinal lymphadenectomy for penile carcinoma patients,” Int. Urol. Nephrol., vol. 48, no. 3, pp. 363–366, Mar. 2016.
V. Kumar and K. K. Sethia, “Prospective study comparing video-endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8-year period,” BJU Int., vol. 119, no. 4, pp. 530–534, Apr. 2017.
M. Vinchant et al., “[Interest of a thrombin and fibrinogen combipatch in preventing breast cancer seroma after lymph node dissection],” Gynecol. Obstet. Fertil., vol. 41, no. 10, pp. 583–587, 2013.
C. Lacoste, L. Ouldamer, G. Body, and H. Marret, “[Does the use of TachoSil allow to reduce the morbidity of axillary dissection?],” Gynecol. Obstet. Fertil., vol. 41, no. 2, pp. 141–143, 2013.
C. Grimm et al., “A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial,” BMC Cancer, vol. 14, no. 1, Aug. 2014.
Copyright (c) 2022 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
